Virtually all patients experienced at least 1 significant late effect.
A unique complication in the very young, dental problems were nearly universal.
Short stature was commonly observed in patients with metabolic diseases (75%).
Seventy-two percent of the assessable patients had normal pubertal development.
Cognitive deficits were more commonly seen with metabolic diseases.